Covadonga Pañeda

1.2k total citations
29 papers, 981 citations indexed

About

Covadonga Pañeda is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Covadonga Pañeda has authored 29 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Endocrine and Autonomic Systems and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Covadonga Pañeda's work include RNA Interference and Gene Delivery (7 papers), Regulation of Appetite and Obesity (5 papers) and Corneal Surgery and Treatments (4 papers). Covadonga Pañeda is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Regulation of Appetite and Obesity (5 papers) and Corneal Surgery and Treatments (4 papers). Covadonga Pañeda collaborates with scholars based in Spain, United States and Switzerland. Covadonga Pañeda's co-authors include Laura M. Frago, Julie A. Chowen, Tamara Martı́nez, Ana I. Jiménez, Jesús Argente, Isabel Varela‐Nieto, Marı́a Victoria González, Natalia Wright, Luı́s de Lecea and Adrian K. Hewson and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Neuroscience and Hepatology.

In The Last Decade

Covadonga Pañeda

29 papers receiving 962 citations

Peers

Covadonga Pañeda
Zihui Xu China
Tongrong Zhou United States
Chang Su United States
Brian Wai Chow United States
Covadonga Pañeda
Citations per year, relative to Covadonga Pañeda Covadonga Pañeda (= 1×) peers Célia A. Aveleira

Countries citing papers authored by Covadonga Pañeda

Since Specialization
Citations

This map shows the geographic impact of Covadonga Pañeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Covadonga Pañeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Covadonga Pañeda more than expected).

Fields of papers citing papers by Covadonga Pañeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Covadonga Pañeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Covadonga Pañeda. The network helps show where Covadonga Pañeda may publish in the future.

Co-authorship network of co-authors of Covadonga Pañeda

This figure shows the co-authorship network connecting the top 25 collaborators of Covadonga Pañeda. A scholar is included among the top collaborators of Covadonga Pañeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Covadonga Pañeda. Covadonga Pañeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carvalho, Tânia, Pedro Andrade, Filipa Cardoso, et al.. (2025). Engineered Neuromedin U Promotes Type 2 Innate Immunity and Renoprotection in Acute Kidney Injury. Journal of the American Society of Nephrology. 36(11). 2120–2130. 2 indexed citations
2.
Saraiva, Sofia M., et al.. (2017). Synthetic nanocarriers for the delivery of polynucleotides to the eye. European Journal of Pharmaceutical Sciences. 103. 5–18. 17 indexed citations
3.
Jiménez, Ana Isabel, José Manuel Benítez del Castillo, Javier Moreno‐Montañés, et al.. (2016). Results of clinical trials with a novel RNA-based therapy (SYL1001) to treat patients with ocular pain associated to dry eye disease. Investigative Ophthalmology & Visual Science. 57(12). 2878–2878. 1 indexed citations
4.
Jiménez, Ana I., Tamara Martı́nez, Victoria González, Carmen Martínez‐García, & Covadonga Pañeda. (2015). Development of a RNAi therapeutic for the treatment of allergic conjunctivitis. Investigative Ophthalmology & Visual Science. 56(7). 4883–4883. 3 indexed citations
5.
González, Victoria, et al.. (2015). Pharmacokinetic and Biosdistribution of Bamosiran in Human and Animal model, a Novel Treatment for Glaucoma. Investigative Ophthalmology & Visual Science. 56(7). 5748–5748. 1 indexed citations
6.
González, Victoria, et al.. (2014). SYL1001, a new treatment based on RNAi for the treatment of ocular pain.. Investigative Ophthalmology & Visual Science. 55(13). 3673–3673. 1 indexed citations
7.
Moreno‐Montañés, Javier, Belén Sádaba, Javier Zarranz‐Ventura, et al.. (2013). Phase I Clinical Trial of SYL040012, a Small Interfering RNA Targeting β-Adrenergic Receptor 2, for Lowering Intraocular Pressure. Molecular Therapy. 22(1). 226–232. 66 indexed citations
8.
Martı́nez, Tamara, Natalia Wright, Marta López‐Fraga, Ana I. Jiménez, & Covadonga Pañeda. (2013). Silencing human genetic diseases with oligonucleotide-based therapies. Human Genetics. 132(5). 481–493. 36 indexed citations
9.
Martı́nez, Tamara, Marı́a Victoria González, Ingo Roehl, et al.. (2013). In Vitro and In Vivo Efficacy of SYL040012, a Novel siRNA Compound for Treatment of Glaucoma. Molecular Therapy. 22(1). 81–91. 88 indexed citations
10.
Pañeda, Covadonga, Salvador Huitrón‐Reséndiz, Laura M. Frago, et al.. (2009). Neuropeptide S Reinstates Cocaine-Seeking Behavior and Increases Locomotor Activity through Corticotropin-Releasing Factor Receptor 1 in Mice. Journal of Neuroscience. 29(13). 4155–4161. 93 indexed citations
11.
Lechuga‐Sancho, Alfonso M., Ana I. Arroba, Laura M. Frago, et al.. (2006). Activation of the intrinsic cell death pathway, increased apoptosis and modulation of astrocytes in the cerebellum of diabetic rats. Neurobiology of Disease. 23(2). 290–299. 42 indexed citations
12.
Conti, Bruno, Shuei Sugama, Jacinta Lucero, et al.. (2005). Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6‐methyl‐phenyl‐tetrahydropyridine toxicity. Journal of Neurochemistry. 93(2). 493–501. 92 indexed citations
13.
Frago, Laura M., Covadonga Pañeda, Jesús Argente, & Julie A. Chowen. (2005). Growth Hormone‐Releasing Peptide‐6 Increases Insulin‐Like Growth Factor‐I mRNA Levels and Activates Akt in RCA‐6 Cells as a Model of Neuropeptide Y Neurones. Journal of Neuroendocrinology. 17(11). 701–710. 15 indexed citations
14.
Marı́, Montserrat, Anna Colell, Albert Morales, et al.. (2004). Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor–induced lethal hepatitis. Journal of Clinical Investigation. 113(6). 895–904. 54 indexed citations
15.
Jones, D. I., Covadonga Pañeda, Ana V. Villar, et al.. (2004). Phosphorylation of glycosyl‐phosphatidylinositol by phosphatidylinositol 3‐kinase changes its properties as a substrate for phospholipases. FEBS Letters. 579(1). 59–65. 6 indexed citations
16.
Arroba, Ana I., Laura M. Frago, Covadonga Pañeda, Jesús Argente, & Julie A. Chowen. (2003). The number of lactotrophs is reduced in the anterior pituitary of streptozotocin-induced diabetic rats. Diabetologia. 46(5). 634–638. 18 indexed citations
17.
Pañeda, Covadonga, Ana I. Arroba, Laura M. Frago, et al.. (2003). Growth hormone-releasing peptide-6 inhibits cerebellar cell death in aged rats. Neuroreport. 14(12). 1633–1635. 22 indexed citations
18.
Pañeda, Covadonga, et al.. (2002). Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulation. Hepatology. 35(6). 1381–1391. 38 indexed citations
19.
Frago, Laura M., Covadonga Pañeda, Isabel Fabregat, & Isabel Varela‐Nieto. (2001). Short-chain ceramide regulates hepatic methionine adenosyltransferase expression. Journal of Hepatology. 34(2). 192–201. 12 indexed citations
20.
Villar, Ana V., Alicia Alonso, Covadonga Pañeda, et al.. (1999). Towards the in vitro reconstitution of caveolae. Asymmetric incorporation of glycosylphosphatidylinositol (GPI) and gangliosides into liposomal membranes. FEBS Letters. 457(1). 71–74. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026